Tag Archives: Toronto

BlissCo Cannabis

Supreme Makes Strategic Investment in Distribution Partner and Secures Supply Agreement with BlissCo

Supreme Makes Strategic Investment in Distribution Partner and Secures Supply Agreement with BlissCo

TORONTO, Ontario, Feb. 26, 2018 /Weed Wire/ — The Supreme Cannabis Company, Inc. (“Supreme Cannabis” or the “Company”) (TSXV:FIRE), is pleased to announce that it has completed a $3,000,000 strategic equity investment (the “Investment”) in BlissCo Cannabis Corp. (“BlissCo”).

CCI

CANNABIS COMPLIANCE INC. (CCI) announces successful retail licence for its client National Access Cannabis (NAC) and gears up for private retail consulting.

TORONTO, Ontario, Feb. 22, 2018 /Weed Wire/ – CANNABIS COMPLIANCE INC. (CCI) of Toronto, Ontario, Canada, is pleased to announce the conditional acceptance for securing cannabis retail licence in Manitoba for National Access Cannabis (NAC).

Aphria Liberty Health sale agreement

Liberty Health Sciences Applauds CSA Notice Regarding Issuers With U.S. Cannabis Investments

TORONTO, Ontario, Feb. 9, 2018 /Weed Wire/ – Liberty Health Sciences Inc. (CSE: LHS or US OTCQX: LHSIF) (the “Company” or “Liberty”) is providing the following statement in response to the Canadian Securities Administration’s (the “CSA”) Staff Notice 51-352 Issuers with U.S. Marijuana-Related Activities (the “Notice”), revised February 8, 2018.

Canadian Securities Regulators Publish Revised Disclosure Expectations for Issuers With US-Related Marijuana Activity

TORONTO, Ontario, Feb. 8, 2018 /Weed Wire/ – The Canadian Securities Administrators (CSA) today published CSA Staff Notice 51-352 (Revised) Issuers with U.S. Marijuana-Related Activities, which sets out CSA staff’s disclosure expectations for specific risks facing issuers with marijuana-related activities in the U.S.

SAQ

Tilray Announces Completion of Series A Funding Round

TORONTO, Ontario, Feb. 8, 2018 /Weed Wire/ – Tilray, a global pioneer in medical cannabis research, cultivation, processing and distribution, today announced the completion of its Series A funding round totaling C$60 million. The round was comprised of a group of leading global institutional investors.

Aphria Liberty Health sale agreement

Liberty Health Sciences Announces New Strategic Investors With Proven Investment Experience In Cannabis Industry

TORONTO, Ontario, Feb. 5, 2018 /Weed Wire/ — Liberty Health Sciences Inc. (CSE: LHS or US OTCBB: LHSIF) (the “Company” or “Liberty”) is pleased to announce today that a group of buyers led by members of the Serruya family (the “Group”) has entered into a purchase and sale agreement with Aphria Inc.

Aphria Liberty Health sale agreement

Aphria And Liberty Health Sciences Announce Definitive Agreement For Sale Of Aphria’s Investment In Copperstate Farms To Liberty

LEAMINGTON AND TORONTO, Ontario, Feb. 2, 2018 /Weed Wire/ — Aphria Inc. (TSX:APH or OTCQB:APHQF) (“Aphria”) and Liberty Health Sciences Inc. (CSE:LHS or OTCQB:LHSIF) (“Liberty”) jointly announce that they have entered into a definitive agreement (the “Agreement”) with respect to the sale (the “Transaction”) of Aphria’s subsidiary Aphria (Arizona) Inc. and its sole holdings being the minority membership interests in Copperstate Farms, LLC and Copperstate Farms Investors, LLC (collectively “Copperstate”) to Liberty for a purchase price of $20 million (“Purchase Price”).

Aphria Liberty Health sale agreement

Liberty Health Sciences Announces Definitive Agreement For The Acquisition Of A 387-Acre Parcel Of Land In Gainesville, Florida

TORONTO, Ontario, Jan. 31, 2018 /Weed Wire/ — Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) (“Liberty” or the “Company”) announced today that it has entered into a definitive share purchase agreement (the “Definitive Agreement”) with 242 Cannabis Canada Ltd. to acquire all of the issued and outstanding shares (the “Purchased Shares”) of its wholly-owned subsidiary, 242 Cannabis, LLC, a Florida limited liability company, which includes a 387-acre parcel of land in Gainesville, Florida (the “Property”) which was previously owned by Alico Citrus Nursery, LLC, a Florida limited liability company (“Alico”).

Here's How U.S. Marijuana Prices Range From Coast to Coast

Here’s How U.S. Marijuana Prices Range From Coast to Coast

Not only do the rules for marijuana consumption vary from state to state, but so do the prices. From coast to coast, marijuana prices in the United States range from just over $7 in the west to nearly $18 in the east.

BlissCo Cannabis

Supreme Secures Supply Agreement with Namaste

TORONTO, Ontario, Jan. 25, 2018 /Weed Wire/ – The Supreme Cannabis Company, Inc. (the “Company” or “Supreme”) (TSXV:FIRE), is pleased to announce that its wholly-owned subsidiary, 8528934 Canada Ltd. (“7ACRES”), has entered into a Definitive Supply Agreement (the “Agreement”) with Cannmart, Inc. (“Cannmart”) a wholly-owned subsidiary of Namaste Technologies Inc.

Canadian Cannabis Research Banks $1.4M in Funding From Government

Canadian Cannabis Research Banks $1.4M in Funding From Government

With the Great White North preparing to become the first G7 nation to launch recreational legalization, the federal government wants to inform its journey into uncharted territory by providing $1.4 million in funding to Canadian cannabis research projects.

Physical Security

Government of Canada Invests in New Cannabis Research

TORONTO, Ontario, Jan. 24, 2018 /Weed Wire/ – The impact of non-medical cannabis use in Canada has been the subject of much speculation and debate. There are still many uncertainties related to the health, social, and economic implications of cannabis legalization and regulation. A solid evidence base is needed for the ongoing development of the most effective policies, practices, and programs relating to the use of cannabis and its derivatives.

Aphria Liberty Health sale agreement

Liberty Health Sciences Opens Inaugural Medical Cannabis Dispensary in Florida in The Villages

TORONTO, Ontario, Jan. 16, 2018 /Weed Wire/ – Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) announced today that it has opened its inaugural medical cannabis dispensary in Florida, strategically located in The Villages, the state’s largest retirement community.

Aphria Liberty Health sale agreement

Liberty Health Sciences Inc. Announces Proposed Acquisition of a 387 Acre Parcel of Land in Gainesville Including 200,000 Square Feet of Greenhouse and Processing Facilities

TORONTO, Ont., Jan. 4, 2018 /Weed Wire/ — Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) (“Liberty” or the “Company”) announced today that it has entered into a binding term sheet to acquire all of the issued and outstanding shares of 242 Cannabis Canada Ltd. (the “242 Shares”), whose wholly-owned subsidiary 242 Cannabis, LLC, has agreed to purchase a 387 acre parcel of land in Gainesville, Florida (the “Property”).

Medical Cannabis Symposium

Khiron Receives Cultivation Quota From Colombian Government and Commences Cultivation

TORONTO, Ontario, Dec. 28, 2017 /Weed Wire/ — Khiron Life Sciences Corp. (“Khiron” or the “Company”) reports that the Company’s wholly owned subsidiary, Khiron Colombia SAS, has commenced cultivation of a variety of medical grade cannabis strains in accordance with the receipt of its medical cannabis quota allocation provided by the Government of Colombia.

BlissCo Cannabis

Supreme Pharmaceuticals Inc. Changes Name to The Supreme Cannabis Company, Inc. and Announces Conversion of Approximately $17.4 Million Aggregate Principal Amount of 10% Unsecured Convertible Debentures Due 2019

TORONTO, Ontario, Dec. 18, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (TSXV: FIRE) is pleased to announce that is has changed its name to “The Supreme Cannabis Company, Inc.” effective today. The name change was approved by the shareholders of the Company at the annual general and special meeting of shareholders held earlier today.

BlissCo Cannabis

Supreme Purchases Adjacent Land for Ultra-Premium Cannabis Facility

TORONTO, Ontario, Dec. 18, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme or the “Company”) (TSXV:FIRE) is pleased to announce the purchase of an approximately six acre property adjacent to the 7ACRES facility in Kincardine, Ontario.

Cooperativa Caucannabis Environmental Impact PharmaCielo

PharmaCielo Partner Cooperativa Caucannabis Announces Receipt of Cannabis Cultivation Licence

RIONEGRO, Colombia and TORONTO, Canada, Dec. 11, 2017 /Weed Wire/ — PharmaCielo Colombia Holdings S.A.S. today announced that its Cauca department-based partner, Cooperativa Caucannabis, a collaborative of small growers, has received its licence for the cultivation of psychoactive cannabis from the Ministry of Justice.

Aphria Liberty Health sale agreement

Liberty Health Sciences Inc. Moves to OTCQX Market

TORONTO, Ontario, Dec. 4, 2017 /Weed Wire/ – Liberty Health Sciences Inc. (CSE:LHS) (OTCBB:LHSIF) (“Liberty” or the “Company”) an industry leading investor and operator in the U.S. medical cannabis market, announced today that it has qualified to trade on the OTCQX® Best Market, an OTC Markets Group Inc. financial market. Liberty upgraded to OTCQX from the Pink® market.

CCI

CCI Appoints Mr. Maurizio Calconi as Vice President for CCI Staffing Solutions, a division of Cannabis Compliance Inc.

OTTAWA, Ontario, Dec. 4, 2017 /Weed Wire/ – Cannabis Compliance Inc., (CCI) of Toronto, Ontario is pleased to announce the appointment of Mr. Maurizio Calconi to the CCI team as VP of CCI’s Staffing Solutions division.

AMO

AMO Calls on Ontario Government to Cover Municipal Cannabis Costs, Share New Taxes With Local Governments

TORONTO, Ont., Nov. 30, 2017 /Weed Wire/ — The Association of Municipalities of Ontario (AMO) President Lynn Dollin was at Queen’s Park today to request that the Government of Ontario cover municipal costs related to the legalization of cannabis, and provide municipalities with a share of tax revenues generated by cannabis sales.

BlissCo Cannabis

Supreme Signs High-Quality Flower Supply LOI Agreement with ABLE BC.

TORONTO, Ontario, Nov. 24, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (TSXV: FIRE) is pleased to announce it has entered into a Letter of Intent (“LOI”) with the Alliance of Beverage Licensees (ABLE BC), the advocacy organization representing BC’s private liquor industry.

Aphria Liberty Health sale agreement

Liberty Health Sciences Inc. Announces Two Additional Dispensary Locations Have Been Secured In Florida

TORONTO, Ontario, Nov. 21, 2017 /Weed Wire/ — Liberty Health Sciences Inc. (CSE:LHS) (OTCBB:LHSIF) (“Liberty” or the “Company”) announced today that it has secured locations for two additional medical cannabis dispensaries in the State of Florida that are scheduled to open in early 2018.

EY: Scaling Up in Canada

Canadian Cannabis Companies Focused on Scaling Up to Meet Anticipated Post-legalization Demand

TORONTO, Ont., Nov. 20, 2017 /Weed Wire/ — Thirty-seven percent of Canadian licensed cannabis producers are focusing on scaling up capacity and production to meet anticipated post-legalization demand, according to a new Canadian EY cannabis study of licensed producers.

BlissCo Cannabis

Supreme Pharmaceuticals Closes $40.25 Million Bought Deal Private Placement of Convertible Debenture Units

TORONTO, Ontario, Nov. 14, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (TSXV:FIRE) is pleased to announce the closing of its previously announced bought deal private placement of 40,250 convertible debenture units (the “Convertible Debenture Units”), including the exercise of the Underwriters’ over-allotment option (the “Offering”), with a syndicate of underwriters, led by Canaccord Genuity Corp., including Beacon Securities Limited, Cormark Securities Inc., Eight Capital, GMP Securities L.P., and PI Financial Corp., for gross proceeds of approximately $40.25 million.

BlissCo Cannabis

Supreme Commences Production in New Flowering Rooms

TORONTO, Ontario, Nov. 7, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (TSXV: FIRE) is pleased to announce 7ACRES has commenced production in the newly constructed flowering rooms recently approved by Health Canada.

Blue Diamond Ventures

BLDV Client, Quality Green Inc., Secures Licensed Producer Status

DENVER and TORONTO, Oct. 30, 2017 /Weed Wire/ — Blue Diamond Ventures, Inc. (OTC PINK: BLDV) will build a state of the art cultivation facility for the newest licensed producer in Ontario, Canada. Quality Green Inc. was added to the Health Canada web-site on Friday making them the 39th licensed grower in Ontario.

Medical Cannabis Symposium

Adent and Khiron Announce Letter of Intent for Proposed Business Combination

TORONTO, Ontario, Oct. 26, 2017 /Weed Wire/ – Khiron Life Sciences Corp. (“Khiron”) and Adent Capital Corp. (“Adent”) (NEX: ANT.H) report that the parties have entered into an arm’s length non-binding letter of intent (the “Letter of Intent”) dated October 25, 2017 in respect of a proposed business combination (the “Proposed Transaction”) that would result in the takeover of Adent by Khiron.

Cooperativa Caucannabis Environmental Impact PharmaCielo

PharmaCielo Becomes Colombia’s First Fully Licensed, Fully Operational Cultivator and Processor of Cannabis Oil Extracts

RIONEGRO, Colombia and TORONTO, Canada, Oct. 24, 2017 /Weed Wire/ — PharmaCielo Colombia Holdings S.A.S., the Colombian subsidiary of PharmaCielo Ltd., has been granted the first Colombian licences for the cultivation of cannabis with unrestricted percentages of tetrahydrocannabinol (THC) and cannabidiol (CBD) alike, becoming the world’s largest licensed producer.

Aphria Liberty Health sale agreement

Liberty Health Sciences Inc. Signs Exclusive Licensing And Raw Materials Agreement With Mary’s Medicinals To Provide Floridians With Range Of Award-Winning Cannabis Products

TORONTO, Ontario, Oct. 24, 2017 /Weed Wire/ — Liberty Health Sciences Inc. (CSE:LHS) (OTCBB:LHSIF) (“Liberty” or the “Company”) today announced a partnership with Colorado-based MM Technology Holdings, LLC (“Mary’s”) to bring its award-winning line of Mary’s Medicinals® cannabis products to the Florida market.

Medical Cannabis Symposium

Khiron First Company to be Fully Licensed for High and Low THC Medical Cannabis in Colombia

TORONTO, Ontario, Oct. 23, 2017 /Weed Wire/ — Khiron Life Sciences Corp. reports that further to its press release dated September 26, 2017, the Company’s wholly owned subsidiary, Khiron Colombia SAS, has been granted all the licences required for the cultivation, production, domestic distribution and international export of both low and high tetrahydrocannabinol (“THC”) medical cannabis in the country of Colombia.

BlissCo Cannabis

Supreme Receives Approval for Increased Capacity at 7ACRES Hybrid Facility

TORONTO, Ontario, Oct. 23, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (TSXV: FIRE) announced today that 7ACRES has obtained the Health Canada approvals necessary to commence cultivation at the recently completed 30,000 sq. ft. flowering rooms at the Company’s Hybrid facility.

Statement from Minister of Community Safety and Correctional Services and Attorney General

TORONTO, Ontario, Oct. 19, 2017 /Weed Wire/ — Marie-France Lalonde, Minister of Community Safety and Correctional Services, and Yasir Naqvi, Attorney General, released the following statement regarding Ontario’s Cannabis Legalization Enforcement Summit.

BlissCo Cannabis

Supreme Pharmaceuticals Announces $30 Million Bought Deal Private Placement of Convertible Debenture Units

TORONTO, Ontario, Oct. 17, 2017 /Weed Wire/ – Supreme Pharmaceuticals Inc. (the “Company”) (TSXV:FIRE) announced today that it has entered into an agreement with Canaccord Genuity Corp., as lead underwriter on behalf of a syndicate of underwriters (the “Underwriters”), pursuant to which the Underwriters have agreed to purchase, on a bought deal, private placement basis, $30,000,000 aggregate principal amount of convertible debenture units (the “Convertible Debenture Units”) at a price of $1,000 per Convertible Debenture Unit.

Canadian Securities Administrators

Canadian Securities Regulators Outline Disclosure Expectations and Certain Risks for Issuers with US Marijuana-Related Activities

TORONTO, Ontario, Oct. 16, 2017 /Weed Wire/ – The Canadian Securities Administrators (CSA) today published CSA Staff Notice 51-352 Issuers with U.S. Marijuana-Related Activities, which among other things, outlines CSA staff’s specific disclosure expectations for issuers that have, or are in the process of developing, marijuana-related activities in the U.S.

Medical Cannabis Symposium

Khiron Advisor Featured as Part of Joint Investigation by 60 Minutes and the Washington Post on U.S. Opioid Crisis

TORONTO, Ontario, Oct. 13, 2017 /Weed Wire/ — Khiron Life Sciences Corp. (“Khiron” or the “Company”) reports that Matthew Murphy, Security and Compliance Advisor to Khiron, and former U.S. DEA Chief of Pharmaceutical Investigations, will be featured as part of a 60 Minutes and Washington Post joint investigation on the U.S. opioid crisis.

Aphria Liberty Health sale agreement

Liberty Health Sciences Inc. and Resolve Digital Health Inc. Strike Exclusive Partnership to Provide Floridians With Innovative Cannabis Metered-Dosing Inhalation Solutions

TORONTO, Ontario, Oct. 11, 2017 /Weed Wire/ – Liberty Health Sciences Inc. (CSE:LHS) (OTCBB:LHSIF) (“Liberty” or the “Company”) today announced an exclusive partnership with Resolve Digital Health Inc. (“Resolve”), a cutting edge developer of medical cannabis delivery systems and devices.

High Robbery: Canada’s Violent Cannabis Dispensary Raids

High Robbery: Canada’s Violent Cannabis Dispensary Raids

With weed legalization on the horizon, dozens of grey-market dispensaries remain open in Toronto. VICE offers a glimpse into the violent cannabis dispensary robberies that are creating a rift between shop owners and police.

Maricann Group

Maricann Group Inc. Partners with International Cannabrands Ltd., and Julian Marley to bring JuJu Royal™ Products to Canada and Western Europe

TORONTO, Ontario, Oct. 6, 2017 /Weed Wire/ — Maricann Group Inc. (CSE:MARI, OTCQB: MRRCF) (“Maricann” or the “Company”), has partnered with Julian Marley and International Cannabrands Ltd. (“International Cannabrands”) a wholly owned subsidiary of GEA Technologies Ltd. (CSE:JUJU.A) to cultivate and formulate JuJu Royal™, a premium and market established group of products.

bayfield strategy 7ACRES Hybrid Facility

Supreme to Quadruple Capacity at 7ACRES Hybrid Facility

TORONTO, Ontario, Oct. 4, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (TSXV: FIRE) is pleased to announce that 7ACRES has completed construction of three additional 10,000 sq. ft. flowering rooms at its Hybrid Facility, and applied to Health Canada for licensing.

CCI

Cannabis Compliance Inc. Announces Strategic Partnership

TORONTO, Ontario, Sept. 29, 2017 /Weed Wire/ – Cannabis Compliance Inc., (CCI) of Toronto, Ontario, Canada, is pleased to announce the formation of a strategic partnership with 2Badgers Consulting Inc. of British Columbia, Canada to explore partnerships between Indigenous Peoples and Industry to develop cannabis based businesses on Indigenous land.

Aphria Liberty Health sale agreement

Liberty Health Sciences Inc.’s License Transfer Application Approved by the Florida Department of Health, Office of Medical Marijuana Use

TORONTO, Ontario, Sept. 29, 2017 /Weed Wire/ — Liberty Health Sciences Inc. (CSE:LHS) (OTCBB:LHSIF) (“Liberty” or the “Company”) today announced that the Florida Department of Health, Office of Medical Marijuana Use, approved the transfer of the license to cultivate, process and dispense medical marijuana in the State from Chestnut Hill Tree Farm LLC (“Chestnut”) to Liberty, effective September 28, 2017.

bayfield strategy 7ACRES Hybrid Facility

Supreme Engages Leading Financial Communications Firm Bayfield Strategy

TORONTO, Ontario, Sept. 28, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (TSXV: FIRE) is pleased to announce that it has retained Bayfield Strategy, Inc. (“Bayfield”) to provide comprehensive Investor and Public Relations.

Toronto-Based Trellis Raises $2.5 Million From Snoop Dogg's Venture Firm

Toronto-Based Trellis Raises $2.5 Million From Snoop Dogg’s Venture Firm

Toronto-based Trellis, which provides cannabis inventory management software, has raised $2.5 million led by Casa Verde Capital.

Medical Cannabis Symposium

Khiron First Company to Receive Licence for Cultivation of Medical Cannabis in Colombia

TORONTO, Ontario, Sept. 26, 2017 /Weed Wire/ — Khiron Life Sciences Corp. (“Khiron” or the “Company”) reports that its wholly owned subsidiary, Khiron Colombia SAS, has been granted the first licence ever issued by the Ministry of Justice for the cultivation of medical cannabis in Colombia.

SP Fire Emerald Health Leadership Team

Supreme Strengthens Leadership Team to Prepare for Next Stage of Growth

TORONTO, Ontario, Sept. 26, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (TSXV: FIRE) is pleased to announce exciting changes and additions to our senior leadership team as the Company prepares for growth.

SP Fire Emerald Health Leadership Team

Supreme Completes Sale with Emerald Health Botanicals Inc.

TORONTO, Ontario, Sept. 20, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (TSXV:FIRE) is pleased to announce its wholly owned subsidiary, 7ACRES, has completed a sale of dried cannabis to Emerald Health Botanicals Inc.


Page 1 of 3123
Top